Securing quality cancer care: Governments must step up to the plat
The OECD recently made a cross-country analysis of how cancer care systems work in an attempt to explain variations in cancer survival in Europe.
The OECD recently made a cross-country analysis of how cancer care systems work in an attempt to explain variations in cancer survival in Europe.
Julio Celis, a scientist to his core, has arguably had the greatest impact in helping shape the structures of Europe’s cancer research effort. Download full article
Progress in treating melanoma has lagged behind many other cancers for decades. But a number of novel approaches are now offering a glimmer of hope. Download full article
Explaining the science which offers new hope to cancer patients. Download full article
The annual week-long course lies at the very heart of ESO’s mission and shapes the oncology leaders of tomorrow. Download full article
How can we transmit knowledge about cancer patients’ needs to the people who have the power to act, in a way they can quickly and easily understand? Download full article
Zoledronic acid is a potent bisphosphonate used as the standard therapy for the prevention of skeletal-related events in patients with solid tumours metastatic to bone. Three phase III studies have reported head-to-head comparisons of zoledronic [more]
A randomised phase III study has reported significant improvements in RO resection rate and overall survival associated with perioperative cisplatin and 5-fluorouracil treatment compared with surgery alone in patients with gastro-oesophageal adenocarcinoma. These data support [more]
Cancer family histories found to be inaccurate Download full article